| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/CCLM.2001.135 |
| P698 | PubMed publication ID | 11601679 |
| P2093 | author name string | M Pesić | |
| O Jovanović | |||
| V Cosić | |||
| S Antić | |||
| S Kundalić | |||
| V B Djordjević | |||
| P2860 | cites work | Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit | Q28141526 |
| Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. | Q42482330 | ||
| Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue | Q44304698 | ||
| The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. | Q50761562 | ||
| Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. | Q51563377 | ||
| Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. | Q51578788 | ||
| Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. | Q51647950 | ||
| Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. | Q54243732 | ||
| P433 | issue | 9 | |
| P921 | main subject | metformin | Q19484 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 818-821 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
| P1476 | title | Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients? | |
| P478 | volume | 39 |
| Q99630326 | A novel mechanism of vitamin D anti-inflammatory/antioxidative potential in type 2 diabetic patients on metformin therapy |
| Q88969340 | Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study |
| Q34436802 | Antioxidants and infertility treatment, the role of Satureja Khuzestanica: A mini-systematic review |
| Q46926316 | Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects |
| Q89820856 | Insulin Resistance Associated with Plasma Xanthine Oxidoreductase Activity Independent of Visceral Adiposity and Adiponectin Level: MedCity21 Health Examination Registry |
| Q43982807 | Metformin decreases platelet superoxide anion production in diabetic patients |
| Q24235718 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q24240522 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q24244739 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q51725045 | The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice. |
| Q54973416 | Xanthine oxidase activity in patients with age-related cataract associated with hypertension. |
| Q46262377 | Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients |
Search more.